A Open-label, Drug-Drug Interaction With SB_MDZ in Healty Adult Subjects

Phase 1 Completed 12 enrolled SPARK Biopharma

NaSingle-groupOpen-labelOther

Summary

This clinical trial is a phase 1, open-label, fixed-sequence, drug-drug interaction study to investigate the effect of single and multiple oral doses of SB17170 on the pharmacokinetics of SB\_MDZ in healthy adult subjects.

Timeline

Start: 2025-03-27
Primary completion: 2025-06-10
Completion: 2025-09-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SB17170	Unknown	—	Oral
Subject	SB_MDZ	Unknown	—	—

Indications

No indication recorded.